<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>European Journal of Endocrinology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'European Journal of Endocrinology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=European+Journal+of+Endocrinology&t=European+Journal+of+Endocrinology&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 15:08:56 +0100</lastBuildDate>
        <item>
            <title>Association of copy number variation in the AHI1 gene with risk of obesity in Chinese population.</title>
            <link>http://www.medworm.com/index.php?rid=5644284&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22285701%26dopt%3DAbstract</link>
            <description>Conclusions: The result suggested that there was a significant linear trend for increasing AHI1 gene copy number frequencies with increasing BMI.
    PMID: 22285701 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5644284</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5644284</guid>        </item>
        <item>
            <title>The risk of elevated resting heart rate on the development of type 2 diabetes in patients with clinically manifest vascular diseases.</title>
            <link>http://www.medworm.com/index.php?rid=5644283&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22285702%26dopt%3DAbstract</link>
            <description>Conclusions. Increased RHR, a reflection of sympathetic nerve activity, is associated with an increased risk for T2DM in patients with manifest vascular diseases, particularly in middle-aged patients.
    PMID: 22285702 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5644283</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5644283</guid>        </item>
        <item>
            <title>Effects of growth hormone in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.</title>
            <link>http://www.medworm.com/index.php?rid=5644287&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22275471%26dopt%3DAbstract</link>
            <description>Conclusion: GH administration in abdominally obese premenopausal women exerts beneficial effects on body composition and cardiovascular risk markers, but is associated with a decrease in glucose tolerance in a minority of women.
    PMID: 22275471 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5644287</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5644287</guid>        </item>
        <item>
            <title>Proteomic profiling of follicular and papillary thyroid tumors.</title>
            <link>http://www.medworm.com/index.php?rid=5644286&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22275472%26dopt%3DAbstract</link>
            <description>Conclusion: The proteins identified confirm previous findings in thyroid proteomics, and suggest additional proteins as dysregulated in thyroid tumors.
    PMID: 22275472 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5644286</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5644286</guid>        </item>
        <item>
            <title>Vitamin D and fertility-a systematic review.</title>
            <link>http://www.medworm.com/index.php?rid=5644285&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22275473%26dopt%3DAbstract</link>
            <description>Discussion: The vitamin D receptor (VDR) and vitamin D metabolizing enzymes are found in reproductive tissues of women and men. VDR knockout mice have significant gonadal insufficiency, decreased sperm count and motility, and histological abnormalities of testis, ovary and uterus. Moreover, we present evidence that vitamin D is involved in female reproduction including in-vitro fertilization (IVF) outcome (clinical pregnancy rates) and polycystic ovary syndrome (PCOS). In PCOS women, low 25-hydroxyvitamin D (25(OH)D) levels are associated with obesity, metabolic and endocrine disturbances and vitamin D supplementation might improve menstrual frequency and metabolic disturbances in those women. Moreover, vitamin D might influence steroidogenesis of sex hormones (estradiol and progesterone) ...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5644285</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5644285</guid>        </item>
        <item>
            <title>Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.</title>
            <link>http://www.medworm.com/index.php?rid=5627194&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22267278%26dopt%3DAbstract</link>
            <description>Conclusions. Patterns of increasing subclinical hypercortisolism in adrenal adenomas are associated with increased prevalence of adverse metabolic and cardiovascular outcomes, independently of other potential risk factors.
    PMID: 22267278 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5627194</comments>
            <pubDate>Fri, 20 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5627194</guid>        </item>
        <item>
            <title>Diagnosis of subclinical central hypothyroidism in patients with hypothalamic-pituitary disease by Doppler echocardiography.</title>
            <link>http://www.medworm.com/index.php?rid=5627193&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22267279%26dopt%3DAbstract</link>
            <description>Conclusion: Echocardiography can be useful in diagnosing subclinical central hypothyroidism in patients with hypothalamic-pituitary disease.
    PMID: 22267279 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5627193</comments>
            <pubDate>Fri, 20 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5627193</guid>        </item>
        <item>
            <title>Distinct Effects of Pioglitazone and Metformin on Circulating Sclerostin and Biochemical Markers of Bone Turnover in Men with Type 2 Diabetes Mellitus.</title>
            <link>http://www.medworm.com/index.php?rid=5627192&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22267280%26dopt%3DAbstract</link>
            <description>Conclusions:Men with T2DM have higher serum sclerostin levels than healthy controls and these levels further increase after treatment with PIO, which is also associated with increased serum CTX. These findings suggest that increased sclerostin production may be involved in the pathogenesis of increased skeletal fragility in patients with T2DM in general, and may specifically contribute to the detrimental effect of TZDs on bone.
    PMID: 22267280 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5627192</comments>
            <pubDate>Fri, 20 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5627192</guid>        </item>
        <item>
            <title>Co-morbidity and cardiovascular risk factors in adult growth hormone deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.</title>
            <link>http://www.medworm.com/index.php?rid=5627196&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22258111%26dopt%3DAbstract</link>
            <description>Conclusion: Adult patients with GHD following treatment for paediatric CD and NFPA have long-term adverse consequences. Despite more severe hypopituitarism in CO-NFPA, patients with CO-CD have more frequently compromised final stature.
    PMID: 22258111 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5627196</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5627196</guid>        </item>
        <item>
            <title>Persistence at 1 Year of Oral Anti-osteoporotic Drugs: a Prospective Study in a Comprehensive Health Insurance Database.</title>
            <link>http://www.medworm.com/index.php?rid=5627195&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22258112%26dopt%3DAbstract</link>
            <description>Conclusion.Overall persistence at 1 year was low, but intermittent regimens were associated with higher persistence rates, along with women who had therapy monitoring.
    PMID: 22258112 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5627195</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5627195</guid>        </item>
        <item>
            <title>Confirmatory Testing in Primary Aldosteronism: Extensive Medication Switching is not Needed in All Patients.</title>
            <link>http://www.medworm.com/index.php?rid=5607254&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22253400%26dopt%3DAbstract</link>
            <description>ConclusionConfirmatory testing performed while the patient is on chronic therapy without diuretics and aldosterone antagonists can confirm the diagnosis of primary aldosteronism, provided serum aldosterone remains markedly elevated at the end of saline infusion.
    PMID: 22253400 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5607254</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5607254</guid>        </item>
        <item>
            <title>Born With Low Birth Weight in Rural Southern India - What Are the Metabolic Consequences 20 Years Later?</title>
            <link>http://www.medworm.com/index.php?rid=5607256&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22250073%26dopt%3DAbstract</link>
            <description>ConclusionThe confirmation of early though subtle features of the metabolic syndrome and changes in body composition among LBW rural Indians supports the idea of foetal programming contributing to the risk of T2D and the metabolic syndrome. Although the alterations in the absolute sense appear mild, factors such as urbanisation and aging may further aggravate and unmask the metabolic abnormalities, linking T2D and the metabolic syndrome with LBW in the Indian population.
    PMID: 22250073 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5607256</comments>
            <pubDate>Mon, 16 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5607256</guid>        </item>
        <item>
            <title>Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly.</title>
            <link>http://www.medworm.com/index.php?rid=5607255&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22250074%26dopt%3DAbstract</link>
            <description>Conclusion: Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly despite similar IGF-1 levels.
    PMID: 22250074 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5607255</comments>
            <pubDate>Mon, 16 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5607255</guid>        </item>
        <item>
            <title>Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation.</title>
            <link>http://www.medworm.com/index.php?rid=5607257&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22247018%26dopt%3DAbstract</link>
            <description>Conclusions: In the growth plate, GH may compensate for decreased local T3 effects on longitudinal bone growth; however, GH does not appear to compensate for the effects of T3 on bone maturation. We believe the present case has important implications for understanding the mechanism of thyroid hormone and GH on longitudinal bone growth and maturation.
    PMID: 22247018 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5607257</comments>
            <pubDate>Fri, 13 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5607257</guid>        </item>
        <item>
            <title>A history of cranial radiotherapy is associated with a higher visceral to subcutaneous fat ratio in men with pituitary insufficiency.</title>
            <link>http://www.medworm.com/index.php?rid=5607260&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22247015%26dopt%3DAbstract</link>
            <description>Conclusion: In men treated for pituitary insufficiency, previous CRT is associated with a higher visceral to subcutaneous fat ratio.
    PMID: 22247015 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5607260</comments>
            <pubDate>Thu, 12 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5607260</guid>        </item>
        <item>
            <title>The natural history of macroprolactinaemia.</title>
            <link>http://www.medworm.com/index.php?rid=5607259&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22247016%26dopt%3DAbstract</link>
            <description>Conclusions: Macroprolactinaemia may develop prior to middle age and is likely a chronic condition leading to hyperprolactinaemia.
    PMID: 22247016 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5607259</comments>
            <pubDate>Thu, 12 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5607259</guid>        </item>
        <item>
            <title>PTHrP-associated hypercalcemia of pregnancy, resolved after delivery: a case report.</title>
            <link>http://www.medworm.com/index.php?rid=5607258&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22247017%26dopt%3DAbstract</link>
            <description>In conclusion, this pregnant patient presented with PTHrP-associated hypercalcemia, presumably of placental origin. Delivery resulted in prompt reduction of serum calcium levels and a transient &quot;hungry bone&quot; syndrome.
    PMID: 22247017 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5607258</comments>
            <pubDate>Thu, 12 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5607258</guid>        </item>
        <item>
            <title>Impaired puberty, fertility and final stature in 45,X/46,XY mixed gonadal dysgenetic patients raised as boys.</title>
            <link>http://www.medworm.com/index.php?rid=5607261&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22236473%26dopt%3DAbstract</link>
            <description>ConclusionsIn summary, 45,X/46,XY children born with ambiguous genitalia and raised as boys have an altered pubertal course and impaired fertility associated with adult short stature, which should therefore be taken into consideration for the management of these patients.
    PMID: 22236473 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5607261</comments>
            <pubDate>Wed, 11 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5607261</guid>        </item>
        <item>
            <title>Increased frequency of the DI genotype of the Angiotensin-I Converting Enzyme (ACE) and association of the II genotype with Insulin Resistance in Polycystic Ovary Syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5580281&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22223701%26dopt%3DAbstract</link>
            <description>Conclusions: The association study of the ACE I/D polymorphism in PCOS women demonstrates an increase in the DI genotype incidence, and an association of the II genotype with IR.
    PMID: 22223701 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580281</comments>
            <pubDate>Thu, 05 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5580281</guid>        </item>
        <item>
            <title>Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5580280&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22223702%26dopt%3DAbstract</link>
            <description>Conclusions: PCOS patients suffer from a systemic inflammatory status that induces erythrocyte membrane alterations. Treatment with MYO is effective in reducing hormonal, metabolic and oxidative abnormalities in PCOS patients by improving insulin resistance.
    PMID: 22223702 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580280</comments>
            <pubDate>Thu, 05 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5580280</guid>        </item>
        <item>
            <title>A mosaic de novo duplication of 17q21-25 is associated with growth hormone insensitivity, disturbed in vitro CD28 mediated signaling and decreased STAT5B, PI3K and NF-κB activation.</title>
            <link>http://www.medworm.com/index.php?rid=5568759&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214923%26dopt%3DAbstract</link>
            <description>Authors: Mul D, Wu S, de Paus R, Oostdijk W, Lankester AC, Duyvenvoorde HV, Ruivenkamp C, Losekoot M, Tol MV, Deluca F, van de Vosse E, Wit JM
    Abstract
    Established causes of growth hormone (GH) insensitivity include defects of the GH receptor and of STAT5b. The latter condition is also characterized by severe immunodeficiency. A recent case with short stature, GH resistance and immunodeficiency due to an IκB mutation, suggests that the NF-κB pathway may interact with STAT5b signaling. Here, we present a case of a short child with several congenital anomalies as well as GH insensitivity and mild immunodeficiency associated with a mosaic de novo duplication of chromosome 17q21-25, suggesting that overexpression of one of the duplicated genes may be implicated in GH resistance. In v...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568759</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5568759</guid>        </item>
        <item>
            <title>Function of Regulatory T Cells Improved by Dexamethasone in Graves' disease.</title>
            <link>http://www.medworm.com/index.php?rid=5568757&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22219499%26dopt%3DAbstract</link>
            <description>Conclusions: DEX could effectively improve the function of Treg cells and set up a new balance of T helper 1(Th1)/Th2 in GD patients. This study might help to further understand the immune mechanism of DEX intrathyroid injection the in treatment of GD and facilitate the potential use of the therapy.
    PMID: 22219499 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568757</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5568757</guid>        </item>
        <item>
            <title>Salivary Cortisol as a Diagnostic Tool for Cushing's Syndrome and Adrenal Insufficiency: Improved Screening by an Automatic Immunoassay.</title>
            <link>http://www.medworm.com/index.php?rid=5568758&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214924%26dopt%3DAbstract</link>
            <description>Conclusions: The newly established thresholds facilitated initial screening for secondary adrenal insufficiency and allowed excellent identification of hypercortisolism. Measurement by an automated immunoassay will allow broader use of salivary cortisol as a diagnostic tool.
    PMID: 22214924 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568758</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5568758</guid>        </item>
        <item>
            <title>Acknowledgement to reviewers.</title>
            <link>http://www.medworm.com/index.php?rid=5538943&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22157913%26dopt%3DAbstract</link>
            <description>Authors: 
    PMID: 22157913 [PubMed - in process] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538943</comments>
            <pubDate>Sun, 25 Dec 2011 11:38:28 +0100</pubDate>
            <guid isPermaLink="false">5538943</guid>        </item>
        <item>
            <title>Identification of Tpit and other novel autoantigens in lymphocytic hypophysitis; immunoscreening of a pituitary cDNA library and development of immunoprecipitation assays.</title>
            <link>http://www.medworm.com/index.php?rid=5538928&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22193973%26dopt%3DAbstract</link>
            <description>Conclusions: Tpit, a corticotroph-specific transcription factor, was identified as a target autoantigen in 10.5% of lymphocytic hypophysitis patients. Further autoantigens related to vesicle processing were also identified as potential autoantigens with different immunoreactivity patterns in patients and controls.
    PMID: 22193973 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538928</comments>
            <pubDate>Thu, 22 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538928</guid>        </item>
        <item>
            <title>Phase II study of weekly paclitaxel and sorafenib as second/third line therapy in patients with adrenocortical carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=5538934&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22189997%26dopt%3DAbstract</link>
            <description>Conclusions: despite the in vitro activity, sorafenib plus weekly paclitaxel is an inactive salvage treatment in patients with advanced ACC and should not be recommended.
    PMID: 22189997 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538934</comments>
            <pubDate>Wed, 21 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538934</guid>        </item>
        <item>
            <title>GH response to GHRH plus arginine (GHRH+ARG) is impaired in lipoatrophic women with human immunodeficiency virus compared with controls.</title>
            <link>http://www.medworm.com/index.php?rid=5538933&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22189998%26dopt%3DAbstract</link>
            <description>Conclusions This study establishes that (i) GH response to GHRH+Arg is lower in lipoatrophic HIV-infected women than in healthy matched controls, (ii) BMI more than VAT or trunk fat influences GH peak in this population, and (iii) HIV-infected women with a GH peak below or equal to 7.5 µg/L demonstrate reduced IGF-1, IGFBP-3, BMD and quality of life.
    PMID: 22189998 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538933</comments>
            <pubDate>Wed, 21 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538933</guid>        </item>
        <item>
            <title>Characterization of adiponectin multimers and the IGF-axis in humans with a heterozygote mutation in the tyrosine kinase domain of the Insulin Receptor Gene.</title>
            <link>http://www.medworm.com/index.php?rid=5538932&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22189999%26dopt%3DAbstract</link>
            <description>Conclusion: The normal levels of adiponectin, IGFBP-1 and IGFBP-2 in the face of highly elevated insulin levels suggest an impaired ability of insulin to suppress markers of common insulin resistance in carriers of a dominant-negative INSR mutation. However, together with the adaptive increases in IGF-I and IGF-II and a potentially improved distribution of adiponectin multimers these changes may contribute to rescue insulin action in insulin receptor deficient individuals.
    PMID: 22189999 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538932</comments>
            <pubDate>Wed, 21 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538932</guid>        </item>
        <item>
            <title>Decrease in Circulating Fibroblast Growth Factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat.</title>
            <link>http://www.medworm.com/index.php?rid=5538931&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22190000%26dopt%3DAbstract</link>
            <description>Conclusions We observed a significant decrease of FGF21 concentration after an oral fat load. Fasting and postprandial FGF21 levels were closely related to large VLDL and remnants, but not to plasma FFA. Our pilot findings suggest that the postprandial accumulation of TRL remnants and liver fat may modulate postprandial FGF21 levels.
    PMID: 22190000 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538931</comments>
            <pubDate>Wed, 21 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538931</guid>        </item>
        <item>
            <title>Testosterone therapy decreased subcutaneous fat and adiponectin in ageing men.</title>
            <link>http://www.medworm.com/index.php?rid=5538930&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22190001%26dopt%3DAbstract</link>
            <description>Conclusion: Our data showed that testosterone therapy decreased subcutaneous fat on the abdomen and lower extremities, but had no significant effect on visceral fat. Moreover, adiponectin levels were significantly decreased during testosterone therapy.
    PMID: 22190001 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538930</comments>
            <pubDate>Wed, 21 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538930</guid>        </item>
        <item>
            <title>Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion.</title>
            <link>http://www.medworm.com/index.php?rid=5538929&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22190002%26dopt%3DAbstract</link>
            <description>Conclusion: Spontaneous and sustained remission of hypercortisolemia is possible in EAS after long-term treatment with steroidogenesis inhibitors; a drug holiday may be warranted during chronic therapy to evaluate for this. The pathophysiology remains unclear but may involve several different mechanisms.
    PMID: 22190002 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538929</comments>
            <pubDate>Wed, 21 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538929</guid>        </item>
        <item>
            <title>Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals.</title>
            <link>http://www.medworm.com/index.php?rid=5538935&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22180452%26dopt%3DAbstract</link>
            <description>Conclusions: In healthy, young adults, prednisone treatment has significant effects on glucose tolerance and bone formation markers within hours of treatment, in parallel with anti-inflammatory effects, after single doses as low as 10 mg.
    PMID: 22180452 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538935</comments>
            <pubDate>Sat, 17 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538935</guid>        </item>
        <item>
            <title>Post-Receptor IGF-1 Insensitivity Restricted to the MAPK Pathway in a Silver-Russell Syndrome Patient with Hypomethylation at the Imprinting Control Region on Chromosome 11.</title>
            <link>http://www.medworm.com/index.php?rid=5538942&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22170793%26dopt%3DAbstract</link>
            <description>Conclusion: A post-receptor IGF-1 insensitivity was characterized in one SRS patient with ICR1 hypomethylation. Albeit our study was based on unique severely affected patient, it raises an intriguing possibility to explain the post-natal growth impairment observed in SRS patients. Analyses of larger cohorts are needed to explore the role of MAPK-pathway defect mediated growth failure in SRS.
    PMID: 22170793 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538942</comments>
            <pubDate>Wed, 14 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538942</guid>        </item>
        <item>
            <title>Fetuin A in non-alcoholic fatty liver disease: in vivo and in vitro studies.</title>
            <link>http://www.medworm.com/index.php?rid=5538941&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22170794%26dopt%3DAbstract</link>
            <description>Conclusions: Fetuin A levels were elevated in NAFLD. Hepatic expression of fetuin A correlated with key enzymes in glucose and lipid metabolism. Metformin decreased fetuin A levels in vitro.
    PMID: 22170794 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538941</comments>
            <pubDate>Wed, 14 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538941</guid>        </item>
        <item>
            <title>Intrauterine and postnatal growth failure with normal growth hormone/insulin-like growth factor-1 axis and insulin resistant diabetes in a consanguineous kinship.</title>
            <link>http://www.medworm.com/index.php?rid=5538940&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22170795%26dopt%3DAbstract</link>
            <description>Conclusions: While the association of IUGR and adult MS, including diabetes, has been well-documented, these subjects did not have typical manifestations of MS. Abnormalities in common components that could result in a combination of IUGR, severe postnatal growth, and insulin resistance have been ruled out. A mutation in an unidentified gene may affect intrauterine and postnatal growth, with insulin resistance directly affected or a result of this growth phenomenon.
    PMID: 22170795 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538940</comments>
            <pubDate>Wed, 14 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538940</guid>        </item>
        <item>
            <title>An Unusual Presentation of Acquired Hypothyroidism: The Van Wyk-Grumbach Syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5538939&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22170796%26dopt%3DAbstract</link>
            <description>We describe an 8-year old girl with autoimmune thyroiditis and severe long standing hypothyroidism presenting with the clinical features of Van Wyk-Grumbach syndrome, a secondary TSH secreting adenoma and hyperprolactinaemia. In addition, this girl presented with microcytic anaemia, elevated ESR and two unusual features - a newly developed streaky hyperpigmented skin lesion and PTH suppression despite vitamin D deficiency. Thyroxine replacement normalized all hormone abnormalities, shrunk the pituitary adenoma within 9 months but the new skin lesion persisted. We review the literature and explore the pathophysiology of known and new features which give rise to speculation indicating stimulation of the FSH G protein coupled receptor by excessive TSH, but LH suppression by hyperprolactinaemi...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538939</comments>
            <pubDate>Wed, 14 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538939</guid>        </item>
        <item>
            <title>Thyroid hyperactivity with high thyroglobulin in serum despite sufficient iodine intake in chronic cold adaption in an Arctic Inuit hunter population.</title>
            <link>http://www.medworm.com/index.php?rid=5538938&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22170797%26dopt%3DAbstract</link>
            <description>Conclusions: Cold exposure influenced thyroid hormones and thyroglobulin in serum in Arctic populations consistent with consumption of thyroid hormone and higher thyroid hormone turnover. Findings emphasise that changes in thyroid activity are essential in cold adaptation in Arctic residents.
    PMID: 22170797 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538938</comments>
            <pubDate>Wed, 14 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538938</guid>        </item>
        <item>
            <title>Automated image analysis of hand radiographs reveals widened joint spaces in patients with long term control of acromegaly: relation to disease activity and symptoms.</title>
            <link>http://www.medworm.com/index.php?rid=5538937&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22170798%26dopt%3DAbstract</link>
            <description>Conclusions: Using a new semi-automated image analysis of hand radiographs, acromegalic patients with long-term disease control appeared to have increased joint spaces of all hand joints. Joint space widths were positively related to disease activity at diagnosis, but not to duration of follow-up, suggesting irreversible cartilage hypertrophy. Irreversible cartilage hypertrophy may partly explain persisting hand complaints, despite long-term disease control.
    PMID: 22170798 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538937</comments>
            <pubDate>Wed, 14 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538937</guid>        </item>
        <item>
            <title>The impact of medication on vitamin D status in older individuals.</title>
            <link>http://www.medworm.com/index.php?rid=5538936&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22170799%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: These data show that users of several medicines have lower serum 25(OH)D than non-users. Vitamin D supplementation may be considered in patients with chronic use of medicines.
    PMID: 22170799 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538936</comments>
            <pubDate>Wed, 14 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538936</guid>        </item>
        <item>
            <title>Fertility, Sexuality and Testicular Adrenal Rest Tumors in Adult Males with Congenital Adrenal Hyperplasia.</title>
            <link>http://www.medworm.com/index.php?rid=5538944&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22157069%26dopt%3DAbstract</link>
            <description>Conclusions: Fertility/fecundity was impaired in CAH males. The frequent occurrence of TARTs resulting in testicular insufficiency appears to be the major cause, but other factors such as elevated fat mass may contribute to a low semen quality.
    PMID: 22157069 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538944</comments>
            <pubDate>Fri, 09 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5538944</guid>        </item>
        <item>
            <title>The relationship of active ghrelin levels and intrauterine growth in preterm infants.</title>
            <link>http://www.medworm.com/index.php?rid=5480776&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22143318%26dopt%3DAbstract</link>
            <description>Conclusion: We found significantly higher active ghrelin levels in SGA preterms than those in AGA preterms and demonstrated a negative correlation between active ghrelin levels and birth weight in preterm infants. This was the first study showing a negative correlation between active ghrelin levels and birth weight in preterm infants.
    PMID: 22143318 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480776</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480776</guid>        </item>
        <item>
            <title>The role of sonoelastography in acute, subacute and chronic thyroiditis - a novel application of the method.</title>
            <link>http://www.medworm.com/index.php?rid=5480775&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22143319%26dopt%3DAbstract</link>
            <description>Conclusions: Sonoelastography may assist in the diagnosis and treatment monitoring of AT, SAT and CAT, as well as in the differentiation of the various types of thyroiditis.
    PMID: 22143319 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480775</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480775</guid>        </item>
        <item>
            <title>Functional characterization of a rare germline mutation in the gene encoding the Cyclin-Dependent Kinase Inhibitor p27Kip1 (CDKN1B) in a Spanish patient with Multiple Endocrine Neoplasia (MEN)-like phenotype.</title>
            <link>http://www.medworm.com/index.php?rid=5480777&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22129891%26dopt%3DAbstract</link>
            <description>Conclusions Our results confirm that germline CDKN1B mutations may predispose to a human MEN4 condition, and add novel evidence that alteration in the transcription/translation rate of CDKN1B mRNA might be the mechanism implicated in tumor susceptibility.
    PMID: 22129891 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480777</comments>
            <pubDate>Wed, 30 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480777</guid>        </item>
        <item>
            <title>Resistance to dopamine agonists in prolactinoma is correlated with reduction of dopamine D2 receptor long isoform mRNA levels.</title>
            <link>http://www.medworm.com/index.php?rid=5480782&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22127489%26dopt%3DAbstract</link>
            <description>Conclusion: Resistance of prolactinoma to dopamine agonists is correlated with a reduction in D(2)L isoform mRNA levels. Silencing of the DRD2 gene by methylation in the promoter region is unlikely to play a role in dopamine agonist resistance in prolactinoma.
    PMID: 22127489 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480782</comments>
            <pubDate>Tue, 29 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480782</guid>        </item>
        <item>
            <title>Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria, but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study.</title>
            <link>http://www.medworm.com/index.php?rid=5480781&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22127490%26dopt%3DAbstract</link>
            <description>Conclusions In type 1 diabetes higher serum HMGB1 levels are associated with greater prevalence and severity of albuminuria, though not with eGFR, retinopathy, and CVD. Prospective studies are needed to clarify the causal role of HMGB1, if any, in the pathogenesis of vascular complications in type 1 diabetes.
    PMID: 22127490 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480781</comments>
            <pubDate>Tue, 29 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480781</guid>        </item>
        <item>
            <title>Ambulatory Arterial Stiffness Indexes in Acromegaly.</title>
            <link>http://www.medworm.com/index.php?rid=5480780&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22127491%26dopt%3DAbstract</link>
            <description>Conclusion: Ambulatory arterial stiffness indexes are increased in acromegaly independently of blood pressure elevation, and may have an important role in predicting cardiovascular risk in this disease.
    PMID: 22127491 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480780</comments>
            <pubDate>Tue, 29 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480780</guid>        </item>
        <item>
            <title>High Prevalence of Hirsutism and Menstrual Disorders in Obese Adolescent Girls and Adolescent Girls with Type 1 Diabetes Mellitus despite Different Hormonal Profiles.</title>
            <link>http://www.medworm.com/index.php?rid=5480779&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22127492%26dopt%3DAbstract</link>
            <description>Conclusions: Hirsutism and menstrual disorders are common in the obese adolescent girls and the adolescent girls with T1DM. Although hyperandrogenaemia is present in both groups of girls, the androgenic profile of the two groups differ. The hyperandrogenaemia in the obese girls is primarily due to their decreased serum SHBG levels, whereas the hyperandrogenaemia in the girls with T1DM is due to their increased androgen production.
    PMID: 22127492 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480779</comments>
            <pubDate>Tue, 29 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480779</guid>        </item>
        <item>
            <title>Serum Inhibin Pro-alphaC is a Tumor Marker for Adrenocortical Carcinomas.</title>
            <link>http://www.medworm.com/index.php?rid=5480778&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22127493%26dopt%3DAbstract</link>
            <description>Conclusions: Inhibin pro-αC is produced by the adrenal gland. Differentiation between ADA and ACC by serum inhibin pro-αC is limited, but its levels may constitute a novel tumor marker for ACC.
    PMID: 22127493 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480778</comments>
            <pubDate>Tue, 29 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480778</guid>        </item>
        <item>
            <title>Associations of Insulin-like Growth Factor-I and its binding proteins with abdominal aortic aneurysm and aortic diameter in older men.</title>
            <link>http://www.medworm.com/index.php?rid=5480783&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22113073%26dopt%3DAbstract</link>
            <description>ConclusionsIn older men, higher IGF-I and an increased ratio of IGF-I/IGFBP3 are associated with AAA, while IGFBP1 is independently associated with increased aortic diameter. Components of the IGF-I system may contribute to, or be a marker for, aortic dilation in ageing men.
    PMID: 22113073 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480783</comments>
            <pubDate>Wed, 23 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480783</guid>        </item>
        <item>
            <title>Gestational diabetes with the WHO and modified International Association of Diabetes and Pregnancy Study Groups criteria: Impact of ethnicity. A population-based cohort study.</title>
            <link>http://www.medworm.com/index.php?rid=5480810&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22108914%26dopt%3DAbstract</link>
            <description>Conclusion GDM prevalence was overall 2.4-times higher with the modified IADPSG criteria compared with the WHO criteria. The new criteria identified many subjects with a relatively mild increase in fasting PG, strongly associated with South Asian origin and prepregnant overweight.
    PMID: 22108914 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480810</comments>
            <pubDate>Tue, 22 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480810</guid>        </item>
        <item>
            <title>Effects of oral and transdermal estrogen on IGF-1, IGFBP-3, IGFBP-1, serum lipids and glucose in patients with hypopituitarism during growth hormone treatment: a randomized study.</title>
            <link>http://www.medworm.com/index.php?rid=5480784&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22108915%26dopt%3DAbstract</link>
            <description>Conclusions: Our preliminary data indicate that different estrogen administration routes can influence IGF-1 and IGFBP-1 levels. These findings in patients with hypopituitarism have an impact on their response to treatment with GH, since patients receiving oral estrogen require increased GH dosage. These results suggest that oral estrogens may reduce the beneficial effects of GH replacement on fat and protein metabolism, body composition, and quality of life.
    PMID: 22108915 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480784</comments>
            <pubDate>Tue, 22 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480784</guid>        </item>
        <item>
            <title>Effects of 3-year growth hormone (GH) replacement therapy on bonemineral density in younger and elderly adults with adult onset GH deficiency.</title>
            <link>http://www.medworm.com/index.php?rid=5480813&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22106341%26dopt%3DAbstract</link>
            <description>Conclusions: This study shows that GH replacement increases lumbar (L2-L4) spine and femur neck BMD and BMC in younger as well as elderly GHD patients. This supports that long-term GH replacement is useful also in elderly GHD patients.
    PMID: 22106341 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480813</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480813</guid>        </item>
        <item>
            <title>REVIEW TOPIC ON MANAGEMENT OF ENDOCRINE DISEASE Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials.</title>
            <link>http://www.medworm.com/index.php?rid=5428198&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22096111%26dopt%3DAbstract</link>
            <description>Conclusions: RT-CGM is more beneficial than SBGM in reducing HbA1c in patients with type 1 diabetes. Further studies are needed to evaluate the efficacy of this system in pediatric population, especially in very young children.
    PMID: 22096111 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428198</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428198</guid>        </item>
        <item>
            <title>REVIEW TOPIC ON MECHANISMS IN ENDOCRINOLOGY Recent Advances in the Cardiovascular Aspects of Polycystic Ovary Syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5428197&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22096112%26dopt%3DAbstract</link>
            <description>Authors: Sathyapalan T, Atkin S
    Abstract
    Polycystic ovary syndrome (PCOS) has been associated with increased cardiovascular risk (CVR) markers, but population studies have not clarified if there is an increase in cardiovascular morbidity and mortality. Four different PCOS phenotypes resulted from the Rotterdam criteria that may differ in their CVR potential introducing further complexity. This has led to studies using surrogate CVR markers including biomarkers in blood as well as by imaging such as flow mediated vasodilatation.  Insulin resistance in PCOS has been shown to be both peripheral and central insulin resistance. Weight loss has been shown to improve insulin resistance and visceral fat, whilst insulin sensitiser therapies with metformin or thiozolididiones improve insulin...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428197</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428197</guid>        </item>
        <item>
            <title>Impaired aerobic exercise adaptation in children and adolescents with craniopharyngioma is associated with hypothalamic involvement.</title>
            <link>http://www.medworm.com/index.php?rid=5428196&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22096113%26dopt%3DAbstract</link>
            <description>Conclusions. Children with craniopharyngioma have a decrease in aerobic capacity mainly related to hypothalamic involvement. The hypothalamic factors altering aerobic capacity remain to be determined.
    PMID: 22096113 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428196</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428196</guid>        </item>
        <item>
            <title>Impact of the Phosphodiesterase 8B gene rs4704397 variation on Thyroid Homeostasis in Childhood Obesity.</title>
            <link>http://www.medworm.com/index.php?rid=5428202&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22084153%26dopt%3DAbstract</link>
            <description>Conclusions: We have i) showed that, in obese children, PDE8B is associated with TSH; ii) demonstrated that the interaction between adiposity and PDE8B on TSH is not synergistic, but follows an additive model iii) highlighted the impact of this association in the stratification of the individual risk to have hyperthyrotropinemia.
    PMID: 22084153 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428202</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428202</guid>        </item>
        <item>
            <title>REVIEW TOPIC ON MECHANISMS IN ENDOCRINOLOGY MicroRNAs: Targets for enhancing osteoblast differentiation and bone formation.</title>
            <link>http://www.medworm.com/index.php?rid=5428201&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22084154%26dopt%3DAbstract</link>
            <description>Authors: Taipaleenmäki H, Bjerre L, Chen L, Kauppinen S, Kassem M
    Abstract
    Osteoblast differentiation and bone formation (osteogenesis) are regulated by transcriptional and post-transcriptional mechanisms. Recently, a novel class of regulatory factors termed microRNAs has been identified as playing an important role in the regulation of many aspects of osteoblast biology including proliferation, differentiation, metabolism and apoptosis. Also, preliminary data from animal disease models suggest that targeting miRNAs in bone can be a novel approach to increase bone mass. This review highlights the current knowledge of microRNA biology and their role in bone formation and discusses their potential use in future therapeutic applications for metabolic bone diseases.
    PMID: 22084154...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428201</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428201</guid>        </item>
        <item>
            <title>Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database.</title>
            <link>http://www.medworm.com/index.php?rid=5428200&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22084155%26dopt%3DAbstract</link>
            <description>ConclusionsAdrenal pathology in MEN1 differs from that observed in sporadic incidentalomas. In the absence of relevant symptoms, endocrine biology can be restricted to patients with adrenal tumours and should focus on steroid secretion including the aldosterone-renin system. MEN1 is a high-risk condition for the occurrence of ACCs. It should be considered regardless of the size of the tumour.
    PMID: 22084155 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428200</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428200</guid>        </item>
        <item>
            <title>The Utility of Basal Serum Luteinizing Hormone in Prediction of Central Precocious Puberty in Girls.</title>
            <link>http://www.medworm.com/index.php?rid=5428199&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22084156%26dopt%3DAbstract</link>
            <description>Conclusion: A single basal lutenizing hormone measurement may be adequate to confirm but not to refute the presence of Central Precocious Puberty in most of the girls who are evaluated for early pubertal signs.
    PMID: 22084156 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428199</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428199</guid>        </item>
        <item>
            <title>Pubertal androgenization and gonadal histology in two 46,xy adolescents with sf-1 mutations and predominantly female phenotype at birth.</title>
            <link>http://www.medworm.com/index.php?rid=5428203&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22080441%26dopt%3DAbstract</link>
            <description>Conclusions: In SF-1 mutations, the neonatal phenotype poorly predicts virilization at puberty. Even in poorly virilized cases at birth, male gender assignment may allow spontaneous puberty without signs of hypogonadotropic hypogonadism, and possibly fertility. Patients with SF-1 mutations are at increased risk for malignant germ cell tumors. In case of preserved gonads, early orchidopexy and germ cell tumor screening is warranted. The finding of premalignant and/or malignant changes should prompt gonadectomy -or possibly irradiation.
    PMID: 22080441 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428203</comments>
            <pubDate>Fri, 11 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428203</guid>        </item>
        <item>
            <title>Cognitive performance after postoperative pituitary radiotherapy: a dosimetric study of the hippocampus and the prefrontal cortex.</title>
            <link>http://www.medworm.com/index.php?rid=5428204&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22071311%26dopt%3DAbstract</link>
            <description>Conclusion: This study showed that there were no significant differences on cognitive performance between the three-, four- and five fields radiotherapy groups and the non-irradiated patient group. Therefore, a dose-response relationship could not be established, even with a radiation dose that was higher on most of the volume of the hippocampus and PFC in case of a 4-fields RT technique compared to the 3- and 5-fields technique.
    PMID: 22071311 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428204</comments>
            <pubDate>Wed, 09 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428204</guid>        </item>
        <item>
            <title>Distribution of the Homeostasis Model Assessment of Insulin Resistance in Mexican children and adolescents.</title>
            <link>http://www.medworm.com/index.php?rid=5428206&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22065856%26dopt%3DAbstract</link>
            <description>Conclusions: Because, the insulin concentrations, glucose levels, and HOMA-IR exhibited a gradual increase with age that was not related to obesity, our results suggested that the evaluation of insulin resistance in children should be based on percentiles of the HOMA-IR rather than a dichotomous value derived from a single cutoff point.
    PMID: 22065856 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428206</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428206</guid>        </item>
        <item>
            <title>DG3173 (Somatoprim), a unique Somatostatin receptor subtype 2-, 4- and 5-selective analogue, effectively reduces GH-secretion in human growth hormone secreting pituitary adenomas even in Octreotide non-responsive tumours.</title>
            <link>http://www.medworm.com/index.php?rid=5428205&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22065857%26dopt%3DAbstract</link>
            <description>Conclusions DG3173 equalled Octreotide in suppressing GH-secretion in hSA. Since DG3173 suppressed GH in some Octreotide-unresponsive adenomas, its clinical effectiveness will be worth testing. Moreover, its reduced insulin-suppressive potency would make it a valuable alternative to Octreotide.
    PMID: 22065857 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428205</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428205</guid>        </item>
        <item>
            <title>Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: A questionnaire survey among members of the European Thyroid Association.</title>
            <link>http://www.medworm.com/index.php?rid=5428207&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22058081%26dopt%3DAbstract</link>
            <description>Conclusions GCs for GO are preferentially given iv in Europe. Both oral and ivGC may be associated with severe adverse effects, including fatal cases, which are more frequently reported using daily or alternate day ivGC. IvGC therapy should be undertaken in centers with appropriate expertise. Patients should be carefully evaluated for risk factors before treatment and monitored for side effects, which may be asymptomatic, both during and after treatment.
    PMID: 22058081 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428207</comments>
            <pubDate>Fri, 04 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428207</guid>        </item>
        <item>
            <title>Primary adrenal angiosarcoma and functioning adrenocortical adenoma: an exceptional composite tumor.</title>
            <link>http://www.medworm.com/index.php?rid=5383468&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048963%26dopt%3DAbstract</link>
            <description>Conclusion: To the best of our knowledge, this is the first case of an adrenal neoplasm combining a primary angiosarcoma and a functioning adrenocortical adenoma.
    PMID: 22048963 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383468</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383468</guid>        </item>
        <item>
            <title>Combined expression of BUB1B, DLG7 and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients.</title>
            <link>http://www.medworm.com/index.php?rid=5383467&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048964%26dopt%3DAbstract</link>
            <description>Conclusion: This study confirms the prognostic value of the combined expression of BUB1B, DLG7 and PINK1 genes in a Brazilian series of adult adrenocortical tumors. Among pediatric ACTs, other molecular predictors of outcome are required.
    PMID: 22048964 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383467</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383467</guid>        </item>
        <item>
            <title>Association of Glucocorticoid Receptor Polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's Syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5383466&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048965%26dopt%3DAbstract</link>
            <description>Conclusions: The A3669G polymorphism of the GR gene plays a protective role in patients with CS, attenuating the effects of glucocorticoid excess on glucose metabolism as shown by their reduced risk of diabetes.
    PMID: 22048965 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383466</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383466</guid>        </item>
        <item>
            <title>Limitations of the IGF-I generation test in children with short stature.</title>
            <link>http://www.medworm.com/index.php?rid=5383465&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048966%26dopt%3DAbstract</link>
            <description>We report the results of a survey undertaken in 2010 to determine the use of the IGFGT amongst members of the European Society for Paediatric Endocrinology (ESPE) to evaluate suspected GHI. The literature surrounding the usefulness and limitations of the IGFGT are reviewed, and recommendations provided for its use.Of 112 pediatric endocrinologists from 30 countries who responded to the survey, 91 (81%) reported that they had used the IGFGT in the previous 2 years; &amp;gt;10 IGFGT protocols were used. The IGFGT impacted treatment decisions for 97% of the respondents, and was a prerequisite for recombinant human IGF-1 (rhIGF-1) treatment for 45% of respondents. From a literature review, sensitivity of the IGFGT was evaluated as 80-85% in molecularly proven cases of GHI; specificity was ≤97%, ...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383465</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383465</guid>        </item>
        <item>
            <title>Effects of Teriparatide in Postmenopausal Women with Osteoporosis Pretreated with Bisphosphonates: 36-month Results from the European Forsteo Observational Study (EFOS).</title>
            <link>http://www.medworm.com/index.php?rid=5383464&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048967%26dopt%3DAbstract</link>
            <description>Conclusions: Postmenopausal women with severe osteoporosis previously treated with bisphosphonates had a significant reduction in the incidence of fractures compared with the first 6 months of therapy, a reduction in back pain and an improvement in HRQoL during up to 18 months of teriparatide treatment. These outcomes were still evident for at least 18 months after teriparatide was discontinued. The results should be interpreted in the context of an uncontrolled, observational study in a routine clinical setting.
    PMID: 22048967 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383464</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383464</guid>        </item>
        <item>
            <title>Association of hypogonadism with vitamin D status: the European Male Ageing Study.</title>
            <link>http://www.medworm.com/index.php?rid=5383463&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048968%26dopt%3DAbstract</link>
            <description>Conclusions: Secondary and compensated hypogonadism were associated with vitamin D deficiency and the clinical significance of this relationship warrants further investigation.
    PMID: 22048968 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383463</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383463</guid>        </item>
        <item>
            <title>Successful treatment of congenital hyperinsulinism with long-acting release octreotide.</title>
            <link>http://www.medworm.com/index.php?rid=5383461&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048969%26dopt%3DAbstract</link>
            <description>ConclusionLAR octreotide is equally efficient and tolerated as subcutaneous octreotide in diazoxide-unresponsive HI patients and contributes to a clear simplification of their medical care.
    PMID: 22048969 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383461</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383461</guid>        </item>
        <item>
            <title>Reproductive function in men affected by x-linked adrenoleukodystrophy/adrenomyeloneuropathy.</title>
            <link>http://www.medworm.com/index.php?rid=5383438&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048970%26dopt%3DAbstract</link>
            <description>Conclusion:We report here that in a group of X-ALD/AMN married adult men, we did not find a significant decrease in fertility compared with the Polish population (18.2% vs 15%).
    PMID: 22048970 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383438</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383438</guid>        </item>
        <item>
            <title>High-dose mitotane strategy in adrenocortical carcinoma (ACC) : prospective analysis of plasma mitotane measurement during the first three months of follow-up.</title>
            <link>http://www.medworm.com/index.php?rid=5383436&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048971%26dopt%3DAbstract</link>
            <description>Conclusion: Employing a high-dose strategy at the time of mitotane initiation enabled therapeutic plasma levels of mitotane to be reached within 1 month in 27% of the total group of patients. If this strategy is adopted, we suggest that mitotane dose is readjusted according to plasma mitotane levels at one or/and two months and patient tolerance.
    PMID: 22048971 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383436</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383436</guid>        </item>
        <item>
            <title>Nuclear receptor nr5a2 and bone: gene expression and association with bone mineral density.</title>
            <link>http://www.medworm.com/index.php?rid=5383435&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048972%26dopt%3DAbstract</link>
            <description>Conclusions. NR5A2 modulates gene expression in osteoblasts and some allelic variants are associated with bone mass in Spanish postmenopausal women.
    PMID: 22048972 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383435</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383435</guid>        </item>
        <item>
            <title>Analysis of plasma ghrelin in patients with medium-chain acyl-CoA dehydrogenase deficiency and glutaric aciduria type II.</title>
            <link>http://www.medworm.com/index.php?rid=5383434&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048973%26dopt%3DAbstract</link>
            <description>Conclusion: Changing serum medium-chain acylcarnitine levels may affect circulating acyl ghrelin levels, suggesting that acyl-CoA is the substrate for ghrelin acylation.
    PMID: 22048973 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383434</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383434</guid>        </item>
        <item>
            <title>Continuous Glucose Monitoring; coming of age?</title>
            <link>http://www.medworm.com/index.php?rid=5383433&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048974%26dopt%3DAbstract</link>
            <description>Authors: Devries JH
    Abstract
    In a recent issue of the Journal of Clinical Endocrinology and Metabolism, an Endocrine Society Clinical Practice Guideline on Continuous Glucose Monitoring is published, co-sponsored by the European Society of Endocrinology. Such a guideline is a necessary step in the maturation of any new technology. This commentary tries to delineate where we stand some ten years after the first retrospective continuous glucose monitoring device entered the market from a European perspective.
    PMID: 22048974 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383433</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383433</guid>        </item>
        <item>
            <title>Evidences that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=5383432&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22048975%26dopt%3DAbstract</link>
            <description>In conclusion, we demonstrated that detoxification genes and apoptotic and cell-cycle control genes are involved in the susceptibility of sporadic MTC and may modulate the susceptibility to the disease.
    PMID: 22048975 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383432</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383432</guid>        </item>
        <item>
            <title>Primary Hypothyroidism and Risk for Breast Cancer: A Systematic Review and Meta-Analysis.</title>
            <link>http://www.medworm.com/index.php?rid=5348160&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22023791%26dopt%3DAbstract</link>
            <description>Conclusions: Our meta-analysis showed that hypothyroidism is not associated with increased risk for breast cancer and thyroid hormone replacement therapy does not reduce breast cancer prevalence however the heterogeneity of the studies analyzed precludes firm conclusions.
    PMID: 22023791 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348160</comments>
            <pubDate>Mon, 24 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5348160</guid>        </item>
        <item>
            <title>Treatment and Screening of Hypothyroidism in Pregnancy: Results of a European Survey.</title>
            <link>http://www.medworm.com/index.php?rid=5348159&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22023792%26dopt%3DAbstract</link>
            <description>Conclusions: There is wide variation in the clinical practice relating to the treatment and screening of hypothyroidism during pregnancy in Europe.
    PMID: 22023792 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348159</comments>
            <pubDate>Mon, 24 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5348159</guid>        </item>
        <item>
            <title>A clinical study on the short term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5348161&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22019891%26dopt%3DAbstract</link>
            <description>Conclusions: Appliance of BBR improved some of the metabolic and hormonal derangements in a group of treated Chinese women with PCOS. Main effects could be related to the changes of body composition in obesity and dyslipidemia. Further controlled studies are needed for the assessment of the potential favourable metabolic effects of BBR in women with PCOS.
    PMID: 22019891 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348161</comments>
            <pubDate>Fri, 21 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5348161</guid>        </item>
        <item>
            <title>Beyond the morphology of the glucose curve following an oral glucose tolerance test in obese youth.</title>
            <link>http://www.medworm.com/index.php?rid=5348162&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22009494%26dopt%3DAbstract</link>
            <description>CONCLUSIONS_Morphologies of the glucose curve seem reflecting different metabolic phenotypes of insulin action and secretion, particularly when combined with morphologies of insulin curve or time of glucose peak. Such findings may deserve validation in cohort study, in which glucose metabolism would be estimated by using gold-standard techniques.
    PMID: 22009494 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348162</comments>
            <pubDate>Tue, 18 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5348162</guid>        </item>
        <item>
            <title>IGF1 and IGFBP3 in the Acute Respiratory Distress Syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5348166&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22004906%26dopt%3DAbstract</link>
            <description>Conclusions: Lower levels of circulating IGF1 and IGFBP3 were independently associated with ARDS case status. Furthermore, lower levels were associated with mortality among ARDS cases. This data supports a role of the IGF pathway in ARDS.
    PMID: 22004906 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348166</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5348166</guid>        </item>
        <item>
            <title>Pitfalls in the diagnosis of thyroid dysgenesis by thyroid ultrasonography and scintigraphy.</title>
            <link>http://www.medworm.com/index.php?rid=5348165&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22004907%26dopt%3DAbstract</link>
            <description>Conclusion: US alone could not differentiate ectopia and athyreosis, whereas scintigraphy alone is also prone to mistakes in newborns and young ages. Dual thyroid imaging is important for precise structural definition of thyroid dysgenesis.
    PMID: 22004907 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348165</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5348165</guid>        </item>
        <item>
            <title>Acylated/unacylated ghrelin ratio in cord blood: correlation with anthropometric and metabolic parameters and pediatric lifespan comparison.</title>
            <link>http://www.medworm.com/index.php?rid=5348164&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22004908%26dopt%3DAbstract</link>
            <description>Conclusions. Neon when compared to children, showed higher UAG and lower AG levels. The AG/UAG ratio showed a very different profile in Neon, being lower than in NW and OB children, thus suggesting a different metabolic function for the two forms for the neonatal age. Further studies are needed to clarify the exact role of the different ghrelin forms in neonates.
    PMID: 22004908 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348164</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5348164</guid>        </item>
        <item>
            <title>Increased Myocardial Fibrosis and Left Ventricular Dysfunction in Cushing's syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5348163&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22004909%26dopt%3DAbstract</link>
            <description>Conclusions: Patients with CS have increased myocardial fibrosis, which is related to LV systolic and diastolic dysfunction. Successful treatment of CS normalizes the extent of myocardial fibrosis. Therefore, myocardial fibrosis appears to be an important factor in the development and potential regression of CS cardiomyopathy.
    PMID: 22004909 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348163</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5348163</guid>        </item>
        <item>
            <title>DISCONTINUATION OF OCTREOTIDE LAR AFTER LONG-TERM, SUCCESFUL TREATMENT OF PATIENTS WITH ACROMEGALY: Is it worth trying?</title>
            <link>http://www.medworm.com/index.php?rid=5317276&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21993154%26dopt%3DAbstract</link>
            <description>Conclusion: Withdrawal of SA is possible in a small but distinct subset of patients, particularly in those who are very well controlled on relatively low doses administered at long intervals.
    PMID: 21993154 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317276</comments>
            <pubDate>Wed, 12 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317276</guid>        </item>
        <item>
            <title>Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?</title>
            <link>http://www.medworm.com/index.php?rid=5317283&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21984611%26dopt%3DAbstract</link>
            <description>Conclusion: Our findings suggest that in PHPT, FGF23 levels are increased independently of 1,25(OH)2D levels. The more pronounced negative relationship between FGF23 and 1,25(OH)2D in the presence of high circulating PTH levels suggests that the increase in FGF23 levels may be an adaptive mechanism to counteract the PTH-induced increase in 1,25(OH)2D levels, although not completely overriding it.
    PMID: 21984611 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317283</comments>
            <pubDate>Fri, 07 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317283</guid>        </item>
        <item>
            <title>Increased IGF-1 levels in an elderly population in relation to heart failure and cardiovascular mortality. Impact of ACE-inhibitors.</title>
            <link>http://www.medworm.com/index.php?rid=5317291&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21976623%26dopt%3DAbstract</link>
            <description>Authors: Chisalita SI, Dahlström U, Arnqvist HJ, Alehagen U
    Abstract
    AbstractObjective. There are conflicting results regarding the association of circulating insulin-like growth factor-1 (IGF-1) with cardiovascular (CV) morbidity and mortality. We assessed the relationship between IGF-1 levels and heart failure (HF), ischemic heart disease (IHD) and CV mortality in an elderly population taking into account the possible impact of angiotensin- converting enzyme inhibitors (ACE-inhibitors).Design and methods. 851 persons aged 66-81 years, in a rural Swedish municipality were evaluated by medical history, clinical examination, electrocardiography, echocardiography and fasting plasma samples. They were then followed for 8 years.Results and conclusion. Patients on ACE-inhibitors had el...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317291</comments>
            <pubDate>Wed, 05 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317291</guid>        </item>
        <item>
            <title>Assessment of androgen concentrations in women: liquid chromatography- tandem mass spectrometry and extraction radioimmunoassay show comparable results.</title>
            <link>http://www.medworm.com/index.php?rid=5284257&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21969522%26dopt%3DAbstract</link>
            <description>Conclusions: LC-MS/MS, compared with a labor intensive extraction RIA, shows good precision, sensitivity and high accuracy for measuring female T, DHEA and AD concentrations under various clinical conditions. LC-MS/MS therefore represents a convenient and reliable assay for both clinical and research purposes in conditions where androgen measurement in women is required.
    PMID: 21969522 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284257</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284257</guid>        </item>
        <item>
            <title>Prevalence and Characteristics of the Metabolic Syndrome in 2479 Hypopituitary Patients with Adult-Onset Growth Hormone (GH) Deficiency before GH Replacement - a KIMS Analysis.</title>
            <link>http://www.medworm.com/index.php?rid=5284256&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21969523%26dopt%3DAbstract</link>
            <description>Conclusions: MetS is highly prevalent in GHD and is associated with a higher prevalence ratio for comorbidities. The presence of MetS in GHD may therefore contribute to the increased risk of cardiovascular morbidity and mortality found in these patients.
    PMID: 21969523 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284256</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284256</guid>        </item>
        <item>
            <title>A critical review and meta-analysis of the association between overt hyperthyroidism and mortality.</title>
            <link>http://www.medworm.com/index.php?rid=5284272&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21724839%26dopt%3DAbstract</link>
            <description>Conclusion In patients diagnosed with hyperthyroidism, mortality is increased by ∼20%. Future studies need to address the cause of hyperthyroidism, impact of type of therapy, time dependency, as well as the potential influence of confounding or genetic susceptibility before the question of causality can be answered.
    PMID: 21724839 [PubMed - in process] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284272</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284272</guid>        </item>
        <item>
            <title>Pregnancy-associated plasma protein A in obese children: relationship to markers and risk factors of atherosclerosis and members of the IGF system.</title>
            <link>http://www.medworm.com/index.php?rid=5284271&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21753069%26dopt%3DAbstract</link>
            <description>Conclusion In this cohort of obese children, PAPPA serum levels correlated significantly with other cardiovascular risk factors. The lack of a direct correlation between PAPPA and IMT suggests that the described association of atherosclerotic plaques and increased PAPPA levels might reflect an indirect mechanism of PAPPA with cardiovascular risk factors such as serum lipids rather than a direct effect on the vasculature.
    PMID: 21753069 [PubMed - in process] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284271</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284271</guid>        </item>
        <item>
            <title>Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals.</title>
            <link>http://www.medworm.com/index.php?rid=5284270&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21768248%26dopt%3DAbstract</link>
            <description>Conclusions This study does not support disadvantageous effects of subclinical thyroid disorders on physical or cognitive function, depression, or mortality in an older population.
    PMID: 21768248 [PubMed - in process] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284270</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284270</guid>        </item>
        <item>
            <title>Fetal and infant growth and the risk of obesity during early childhood: the Generation R Study.</title>
            <link>http://www.medworm.com/index.php?rid=5284269&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21775498%26dopt%3DAbstract</link>
            <description>Conclusion Fetal growth characteristics strongly influence infant growth rates. A higher PWV, which generally occurs in the first month after birth, was associated with an increased risk of overweight and obesity at 4 years of age. Longer follow-up studies are necessary to determine how fetal and infant growth patterns affect the risk of disease in later life.
    PMID: 21775498 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284269</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284269</guid>        </item>
        <item>
            <title>'Idiopathic' partial androgen insensitivity syndrome in 28 newborn and infant males: impact of prenatal exposure to environmental endocrine disruptor chemicals?</title>
            <link>http://www.medworm.com/index.php?rid=5284268&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21788424%26dopt%3DAbstract</link>
            <description>Conclusions Our results indicate that the 'idiopathic' PAIS-like phenotype may in some cases be related to EDC contamination during fetal life.
    PMID: 21788424 [PubMed - in process] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284268</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284268</guid>        </item>
        <item>
            <title>Isolated GH deficiency: mutation screening and copy number analysis of HMGA2 and CDK6 genes.</title>
            <link>http://www.medworm.com/index.php?rid=5284267&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21803798%26dopt%3DAbstract</link>
            <description>Conclusions This study provides the first report of a deletion in the HMGA2 gene that might be related to IGHD. We suggest that this gene is investigated as a second screening in patients with a classical IGHD phenotype in which mutations in classical candidate genes have been excluded.
    PMID: 21803798 [PubMed - in process] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284267</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284267</guid>        </item>
        <item>
            <title>Identification of somatostatin receptor type 5 gene polymorphisms associated with acromegaly.</title>
            <link>http://www.medworm.com/index.php?rid=5284266&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810856%26dopt%3DAbstract</link>
            <description>Conclusions Our results demonstrate a previously undetected strong association of two SSTR5 SNPs with acromegaly. The data also suggest a possible involvement of SSTR5 variants in decreased suppression of GH production and increased tumor proliferation.
    PMID: 21810856 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284266</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284266</guid>        </item>
        <item>
            <title>Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomy.</title>
            <link>http://www.medworm.com/index.php?rid=5284265&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21813593%26dopt%3DAbstract</link>
            <description>Conclusions Our results implicate peripheral deiodination in the peculiar hormonal constellation of MCT8-deficient patients. Other MCT8-deficient patients should be closely monitored for potential thyroid abnormalities.
    PMID: 21813593 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284265</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284265</guid>        </item>
        <item>
            <title>Altered urinary excretion of aquaporin 2 in IgA nephropathy.</title>
            <link>http://www.medworm.com/index.php?rid=5284264&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21824900%26dopt%3DAbstract</link>
            <description>Conclusion Our findings would support the involvement of AVP-AQP2 axis, interacting with the RAS, in the progression of IgAN and candidate AQP2 as a possible novel marker of the disease.
    PMID: 21824900 [PubMed - in process] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284264</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284264</guid>        </item>
        <item>
            <title>The European Journal of Endocrinology: changing of the guard.</title>
            <link>http://www.medworm.com/index.php?rid=5284263&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21957122%26dopt%3DAbstract</link>
            <description>Authors: Romijn JA, Strasburger CJ
    PMID: 21957122 [PubMed - in process] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284263</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284263</guid>        </item>
        <item>
            <title>Testicular function and physical outcome in young adult males diagnosed with idiopathic 46 XY disorders of sex development during childhood.</title>
            <link>http://www.medworm.com/index.php?rid=5284262&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21964959%26dopt%3DAbstract</link>
            <description>Conclusion: Men diagnosed with idiopathic 46 XY DSD during childhood are at high risk of testicular insufficiency and persistent micropenis, and this should be taken into account during follow-up.
    PMID: 21964959 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284262</comments>
            <pubDate>Fri, 30 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284262</guid>        </item>
        <item>
            <title>Growth hormone deficiency in patients after cure of acromegaly by surgery alone.</title>
            <link>http://www.medworm.com/index.php?rid=5284261&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21964960%26dopt%3DAbstract</link>
            <description>Conclusions: This is the first large-scale, single-center, clinical study to evaluate sGHD in patients after cure of acromegaly by surgery alone. This study found that sGHD occurred in approximately 9% of patients and assessment of GHD by stimulation tests is critical after successful treatment of acromegaly by surgery.
    PMID: 21964960 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284261</comments>
            <pubDate>Fri, 30 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284261</guid>        </item>
        <item>
            <title>Evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism.</title>
            <link>http://www.medworm.com/index.php?rid=5284260&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21964961%26dopt%3DAbstract</link>
            <description>Authors: Bollerslev J, Marcocci C, Henriques MS, Nordenström J, Bouillon R, Mosekilde L
    Abstract
    Management of patients with mild primary hyperparathyroidism (PHPT) has been widely discussed because most patients today do not have specific symptoms. While surgery is always an option, the recommendations for treatment have shifted, which mostly reflects changes in clinical practice. In this review, we aimed to evaluate evidence for the current recommendations concerning operation versus observation, repletion with vitamin D, and alternative medical management.Surgery is followed by normalisation of calcium and PTH and a decrease in bone turnover followed by an increase in bone mass. It is not known what the consequences would be for the frequency of fractures. Randomised studies ha...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284260</comments>
            <pubDate>Thu, 29 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284260</guid>        </item>
        <item>
            <title>Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways.</title>
            <link>http://www.medworm.com/index.php?rid=5284259&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21964962%26dopt%3DAbstract</link>
            <description>Conclusions: Heavy smoking was significantly associated with T2DM, and this association was moderated by CYP2A6 genotype and mediated by serum cotinine, abdominal obesity, insulin resistance and insulin secretion.
    PMID: 21964962 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284259</comments>
            <pubDate>Thu, 29 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284259</guid>        </item>
        <item>
            <title>Decreased concentration of adiponectin together with a selective reduction of its high molecular weight oligomers are involved in metabolic complications of myotonic dystrophy type 1.</title>
            <link>http://www.medworm.com/index.php?rid=5284258&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21964963%26dopt%3DAbstract</link>
            <description>Conclusions: Our results endorse the hypothesis that decreased expression of adiponectin together with a selective reduction of its high molecular weight oligomers contribute to the worsening of insulin resistance and its metabolic complications in DM1 patients. These findings suggest that adiponectin and high molecular weight oligomers may serve as biomarkers, and are promising therapeutic agents for insulin resistance and its consequences in DM1.
    PMID: 21964963 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284258</comments>
            <pubDate>Thu, 29 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284258</guid>        </item>
        <item>
            <title>Serum sex steroids measured in middle-aged european and african-caribbean men using gas chromatography-mass spectrometry.</title>
            <link>http://www.medworm.com/index.php?rid=5268615&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951700%26dopt%3DAbstract</link>
            <description>Conclusions. Significant differences in serum steroid hormone levels were observed in middle-aged African-Caribbean and European men. Whether such differences could contribute to ethnic differences in disease risk in adult men remains to be investigated. Some steroids, such as bioavailable testosterone, 4-androstenedione, 5-androstenediol, and estrone deserve particular attention.
    PMID: 21951700 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5268615</comments>
            <pubDate>Tue, 27 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5268615</guid>        </item>
        <item>
            <title>Neonatal presentation of Familial Glucocorticoid Deficiency resulting from a novel splice mutation in the melanocortin 2 receptor accessory protein.</title>
            <link>http://www.medworm.com/index.php?rid=5268614&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951701%26dopt%3DAbstract</link>
            <description>Conclusion: We have identified a novel MRAP mutation where disruption of the intron 3 splice-site results in a prematurely terminated translation product. This protein (if produced) would lack the transmembrane domain that is essential for MC2R interaction. We predict that this would cause complete lack of ACTH response thus explaining the early presentation in this case.
    PMID: 21951701 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5268614</comments>
            <pubDate>Tue, 27 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5268614</guid>        </item>
        <item>
            <title>ATLANTIC DIP: High prevalence of abnormal glucose tolerance postpartum is reduced by breast-feeding in women with prior gestational diabetes mellitus.</title>
            <link>http://www.medworm.com/index.php?rid=5249679&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21937504%26dopt%3DAbstract</link>
            <description>Conclusions:Non-European ethnicity, gestational insulin use, family history of T2DM and elevated BMI were associated with persistent dysglycemia after GDM. Breast-feeding may confer beneficial metabolic effects after GDM and should be encouraged.
    PMID: 21937504 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5249679</comments>
            <pubDate>Wed, 21 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5249679</guid>        </item>
        <item>
            <title>Fatty Liver Index in Polycystic Ovary Syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5249678&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21937505%26dopt%3DAbstract</link>
            <description>Conclusion: High FLI levels are a common finding in obese PCOS women and are closely linked to MS. FLI calculation might be a useful tool for identifying PCOS patients at high risk for metabolic and hepatic disturbances.
    PMID: 21937505 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5249678</comments>
            <pubDate>Wed, 21 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5249678</guid>        </item>
        <item>
            <title>Insulin initiation in patients with type 2 diabetes mellitus: Treatment guidelines, clinical evidence and patterns of use of basal versus premixed insulin analogues.</title>
            <link>http://www.medworm.com/index.php?rid=5249680&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21930715%26dopt%3DAbstract</link>
            <description>Authors: Vaag A, Lund SS
    Abstract
    This review addresses the apparent disconnect between international guideline recommendations, real-life clinical practice and the results of clinical trials, with regard to the initiation of insulin using basal (long-acting) or premixed insulin analogues in patients with type 2 diabetes (T2D). English language guidelines vary considerably with respect to recommended glycaemic targets, the selection of human versus analogue insulin, and choice of insulin regimen. Randomized trials directly comparing insulin initiation between basal and premixed analogues are scarce, and hard endpoint outcome data is inadequate. The evidence presented suggests that the major component of the HbA1c not being attained in every day clinical practice may be a result of ...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5249680</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5249680</guid>        </item>
        <item>
            <title>The estimation of selected endogenous anticoagulation system parameters in patients with Subclinical Cushing's Syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5221687&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21914670%26dopt%3DAbstract</link>
            <description>Conclusions: The patients with SCS present disturbances in endogenous anticoagulant system defined as PC, FPS activity and TM concentration. This finding suggests an impact of mild autonomic cortisol overproduction on coagulation system.
    PMID: 21914670 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221687</comments>
            <pubDate>Tue, 13 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221687</guid>        </item>
        <item>
            <title>Incidence of Hyperthyroidism in Sweden.</title>
            <link>http://www.medworm.com/index.php?rid=5221688&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21908653%26dopt%3DAbstract</link>
            <description>Conclusion: The incidence of hyperthyroidism in Sweden is in a lower range compared to international reports. Patients with hyperthyroidism had GD in 75% and 20% of them had thyroid associated eye symptoms/-signs at diagnosis. The observed geographical differences require further studies.
    PMID: 21908653 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221688</comments>
            <pubDate>Fri, 09 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221688</guid>        </item>
        <item>
            <title>Influence of Bone Remodeling Rate on Quantitative Ultrasound (QUS) Parameters at the Calcaneus and DXA BMDa of the Hip and Spine in Middle Aged and Elderly European Men: The European Male Ageing Study (EMAS).</title>
            <link>http://www.medworm.com/index.php?rid=5221690&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21903895%26dopt%3DAbstract</link>
            <description>Conclusions: Oestradiol, SHBG, IGF-I and PTH contribute significantly to the regulation / rate of bone turnover in middle-aged and older European men. Higher rates of bone remodeling are negatively associated with male bone health.
    PMID: 21903895 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221690</comments>
            <pubDate>Thu, 08 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221690</guid>        </item>
        <item>
            <title>Diabetes reduces left-ventricular ejection fraction - irrespective of CAD presence and extent.</title>
            <link>http://www.medworm.com/index.php?rid=5221689&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21903896%26dopt%3DAbstract</link>
            <description>Conclusion: Diabetics had a lower LVEF than non-diabetics. This difference could be demonstrated regardless of CAD extent and might in part explain their generally worse cardiac survival compared to non-diabetic patients on an epidemiological level. In addition, this finding points to other discussed mechanisms than CAD lowering LVEF in diabetic patients.
    PMID: 21903896 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221689</comments>
            <pubDate>Thu, 08 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221689</guid>        </item>
        <item>
            <title>Can we ever stop imaging in surgically treated and radiotherapy naive patients with non-functioning pituitary adenoma?</title>
            <link>http://www.medworm.com/index.php?rid=5221691&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21900406%26dopt%3DAbstract</link>
            <description>Conclusion:These results suggest that patients with NFAs need to be closely monitored following surgery particularly those with post operative tumour remnants. With 20% of relapse occurring after 10 years, follow up surveillance needs to be continued beyond this time.
    PMID: 21900406 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221691</comments>
            <pubDate>Wed, 07 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221691</guid>        </item>
        <item>
            <title>Grapefruit juice and liquorice increase cortisol availability in patients with Addison's disease.</title>
            <link>http://www.medworm.com/index.php?rid=5221695&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21896619%26dopt%3DAbstract</link>
            <description>Conclusion: Liquorice and in particular GFJ increased cortisol available to tissues in the hours following oral CA administration. Both patients and physicians should be aware of these interactions, and we recommend that circulating levels of cortisol should be monitored in habitual users.
    PMID: 21896619 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221695</comments>
            <pubDate>Tue, 06 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221695</guid>        </item>
        <item>
            <title>REVIEW TOPIC: GENETICS IN ENDOCRINOLOGY The genetics of phaeochromocytoma - using clinical features to guidegenetic testing.</title>
            <link>http://www.medworm.com/index.php?rid=5221694&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21896620%26dopt%3DAbstract</link>
            <description>Authors: Jafri M, Maher E
    Abstract
    Phaeochromocytoma is a rare, usually benign, tumour predominantly managed by endocrinologists. Over the last decade, major advances have been made in understanding the molecular genetic basis of adrenal and extra-adrenal phaeochromocytoma (also referred to as adrenal phaeochromocytoma (aPCA) and extra-adrenal functional paraganglioma (eFPGL)). In contrast to the previously held belief that only 10% of cases had a genetic component, currently about one third of all aPCA/eFPGL cases are thought to be attributable to germline mutations in at least nine genes (NF1, RET, SDHA, SDHB, SDHC, SDHD, TMEM127, MAX, and VHL). Recognition of inherited cases of aPCA/eFPGL is critical for optimal patient management. Thus, the identification of a germline mutation...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221694</comments>
            <pubDate>Tue, 06 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221694</guid>        </item>
        <item>
            <title>Child with a deletion in the monocarboxylate transporter 8 gene: seven-year follow-up and effects of thyroid hormone treatment.</title>
            <link>http://www.medworm.com/index.php?rid=5221693&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21896621%26dopt%3DAbstract</link>
            <description>Conclusion We identified a 70 kb deletion encompassing exons 2-6 of the MCT8 gene in our AHDS patient. Both LT4 and LT3 administration had no therapeutic effect. Alternatively, treatment of AHDS patients with thyroid hormone analogs should be considered.
    PMID: 21896621 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221693</comments>
            <pubDate>Tue, 06 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221693</guid>        </item>
        <item>
            <title>Impact of hormonal, radiological and immunohistochemical studies on the diagnosis of post menopausal hyperandrogenism.</title>
            <link>http://www.medworm.com/index.php?rid=5221692&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21896622%26dopt%3DAbstract</link>
            <description>Conclusions: Androgen-secreting tumors are clinically difficult to discriminate from other causes of postmenopausal hyperandrogenism. Testosterone and FSH were the 2 discriminative markers in a multivariate analysis. Ovarian and adrenal tumors were detected by imaging studies. However, ovarian non tumoral causes of hyperandrogenism may be difficult to detect with conventional histology.
    PMID: 21896622 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221692</comments>
            <pubDate>Tue, 06 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221692</guid>        </item>
        <item>
            <title>REVIEW TOPIC: ENDOCRINE DISORDERS IN PREGNANCY Phaeochromocytoma and pregnancy:a deceptive connection.</title>
            <link>http://www.medworm.com/index.php?rid=5221698&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21890650%26dopt%3DAbstract</link>
            <description>Authors: Lenders J
    Abstract
    A phaeochromocytoma in a pregnant patient is one of the most threatening medical conditions for both mother, fetus and physician. Although extraordinarily rare with a frequency of 0.002% of all pregnancies, this tumour is notorious for its devastating consequences. As in non-pregnant patients, signs and symptoms are quite variable but not specific with hypertension as one of the most prominent signs. Confusion with the much more prevalent forms of pregnancy-related hypertension is the main cause of overlooking the diagnosis. If undiagnosed, maternal and fetal mortality is around 50%. Conversely, early detection and proper treatment during pregnancy decreases maternal and fetal mortality to less than 5% and 15% respectively. For the biochemical diagnosis ...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221698</comments>
            <pubDate>Fri, 02 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221698</guid>        </item>
        <item>
            <title>REVIEW TOPIC: ENDOCRINE TUMOURS Approach to the patient with advanced differentiated thyroid cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5221697&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21890651%26dopt%3DAbstract</link>
            <description>Authors: Schlumberger M, Sherman S
    Abstract
    Patients with advanced thyroid cancer may benefit from l-thyroxine treatment at doses that suppress serum TSH level, local treatment interventions and radioiodine therapy. In those patients who are refractory to radioiodine therapy and in whom progressive disease has been documented, the efficacy of cytotoxic chemotherapy is poor. Encouraging results have been obtained with the use of kinase inhibitors that should be offered as first line treatment, preferably in the context of a prospective trial.
    PMID: 21890651 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221697</comments>
            <pubDate>Fri, 02 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221697</guid>        </item>
        <item>
            <title>Family history of diabetes and distribution of class II HLA genotypes in children with newly diagnosed type 1 diabetes: effect on diabetic ketoacidosis.</title>
            <link>http://www.medworm.com/index.php?rid=5221696&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21890652%26dopt%3DAbstract</link>
            <description>Conclusion: The presence of type 1 diabetes in a FDR is associated with a decreased risk of DKA at diagnosis. The rate of DKA seems to be higher in children with lower HLA-conferred risk for type 1 diabetes.
    PMID: 21890652 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221696</comments>
            <pubDate>Fri, 02 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221696</guid>        </item>
        <item>
            <title>Sequential hormonal changes in 21 patients with recurrent Cushing's disease after successful pituitary surgery.</title>
            <link>http://www.medworm.com/index.php?rid=5195586&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21885674%26dopt%3DAbstract</link>
            <description>Conclusion: A positive response to Vasopressin analogs and/or CRH tests occurs early in recurrence, followed by an increase in midnight cortisol, while UC elevation is a later stage.
    PMID: 21885674 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5195586</comments>
            <pubDate>Wed, 31 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5195586</guid>        </item>
        <item>
            <title>Circulating Lipocalin-2 is associated with body fat distribution at baseline, but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism Study.</title>
            <link>http://www.medworm.com/index.php?rid=5195585&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21885675%26dopt%3DAbstract</link>
            <description>Conclusions: We demonstrate that lipocalin-2 is not an independent predictor of metabolic and cardiovascular risk factors in young men cross-sectionally or prospectively.
    PMID: 21885675 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5195585</comments>
            <pubDate>Wed, 31 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5195585</guid>        </item>
        <item>
            <title>Minimal impact of excess iodate intake on thyroid hormones and selenium status in older New Zealanders.</title>
            <link>http://www.medworm.com/index.php?rid=5180411&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21878580%26dopt%3DAbstract</link>
            <description>Conclusions: Excess iodate induced hypothyroidism in some participants and hyperthyroidism in others. Most abnormalities disappeared after 4 weeks. Excess iodate reduced WBGPx activity and resulted in smaller increases in WBGPx after selenium supplementation.
    PMID: 21878580 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5180411</comments>
            <pubDate>Mon, 29 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5180411</guid>        </item>
        <item>
            <title>Relationship of fibroblast growth factor 23 with cardiovascular disease in older community-dwelling women.</title>
            <link>http://www.medworm.com/index.php?rid=5180412&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21873490%26dopt%3DAbstract</link>
            <description>Conclusion: Elevated serum FGF23 concentrations are independently associated with prevalent cardiovascular disease in older community-dwelling women. Further studies are needed to elucidate the potential biological mechanisms by which FGF23 may be involved in the pathogenesis of cardiovascular disease.
    PMID: 21873490 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5180412</comments>
            <pubDate>Thu, 25 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5180412</guid>        </item>
        <item>
            <title>Determinants of cardiac disease in newly diagnosed patients with acromegaly. Results of a 10 years survey study.</title>
            <link>http://www.medworm.com/index.php?rid=5180414&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21868601%26dopt%3DAbstract</link>
            <description>Conclusions The prevalence of different features of cardiomyopathy is 3.3-14.2 times higher in the acromegalic than in the non-acromegalic population. The major determinant of cardiomyopathy is disease duration.
    PMID: 21868601 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5180414</comments>
            <pubDate>Wed, 24 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5180414</guid>        </item>
        <item>
            <title>A case of acromegaly (Greece, 7th c. AD).</title>
            <link>http://www.medworm.com/index.php?rid=5180413&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21868602%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: This skeletal case, and other ancient ones are discussed, in order to better describe the history of the disease, and the possibilities of diagnosis.
    PMID: 21868602 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5180413</comments>
            <pubDate>Wed, 24 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5180413</guid>        </item>
        <item>
            <title>Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5160403&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21865408%26dopt%3DAbstract</link>
            <description>Conclusions: Plasma levels of omentin-1 were reduced in non-obese women with PCOS and NGT. Postprandial hyperinsulinemia and hyperglycemia contributed more to lower omentin-1 levels than did fasting values in the setting of PCOS. Increased androgen levels contributed to decreased omentin-1 levels in women with PCOS.
    PMID: 21865408 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5160403</comments>
            <pubDate>Tue, 23 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5160403</guid>        </item>
        <item>
            <title>Body Composition and Quality of Life in Adults Treated with Growth Hormone Therapy: A Systematic Review and Meta-analysis.</title>
            <link>http://www.medworm.com/index.php?rid=5160402&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21865409%26dopt%3DAbstract</link>
            <description>Conclusion: Growth hormone therapy in adults with confirmed GH deficiency reduces weight and body fat, increases lean body mass and increases edema and joint stiffness. Most trials demonstrated improvement in quality of life measures.
    PMID: 21865409 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5160402</comments>
            <pubDate>Tue, 23 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5160402</guid>        </item>
        <item>
            <title>Patients with surgically cured primary hyperparathyroidism a have reduced quality of life compared to population based healthy sex-, age-, and season-matched controls.</title>
            <link>http://www.medworm.com/index.php?rid=5160404&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21862666%26dopt%3DAbstract</link>
            <description>Conclusion: Even though QoL may improve substantially after surgery, former PHPT patients still have reduced QoL compared to healthy controls.
    PMID: 21862666 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5160404</comments>
            <pubDate>Mon, 22 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5160404</guid>        </item>
        <item>
            <title>Exercise-induced Growth Hormone Secretion in the Assessment of Growth Hormone Deficiency in Adult Individuals.</title>
            <link>http://www.medworm.com/index.php?rid=5160406&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21856788%26dopt%3DAbstract</link>
            <description>Conclusion GH assessment during a standardized aerobic exercise of moderate intensity is a reliable test with high diagnostic accuracy in predicting severe GHD in adult individuals. Based on the current findings an exercise duration of 60 minutes appears to be sufficient for diagnostic purposes.
    PMID: 21856788 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5160406</comments>
            <pubDate>Thu, 18 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5160406</guid>        </item>
        <item>
            <title>The Accuracy of Diagnostic Tests for Growth Hormone Deficiency in Adults: A Systematic Review and Meta-analysis.</title>
            <link>http://www.medworm.com/index.php?rid=5160405&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21856789%26dopt%3DAbstract</link>
            <description>Conclusion: Several tests with reasonable diagnostic accuracy are available for the diagnosis of growth hormone deficiency in adults. The supporting evidence, however, is at high risk of bias (due to heterogeneity, methodological limitations, and imprecision).
    PMID: 21856789 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5160405</comments>
            <pubDate>Thu, 18 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5160405</guid>        </item>
        <item>
            <title>Denosumab for bone diseases - Translating bone biology into targeted therapy.</title>
            <link>http://www.medworm.com/index.php?rid=5142968&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21852390%26dopt%3DAbstract</link>
            <description>This article summarizes the molecular and cell biology of the RANKL/RANK system and critically reviews preclinical and clinical studies that have established denosumab as a promising novel therapy for metabolic and malignant bone diseases. We will discuss the potential indications for denosumab along with a critical review of safety and analyze its potential within the concert of established therapies. This article is based on the presentation for the European Journal of Endocrinology Prize Lecture 2010 by L C Hofbauer at the European Congress of Endocrinology Meeting at Prague, Czech Republic.
    PMID: 21852390 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5142968</comments>
            <pubDate>Wed, 17 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5142968</guid>        </item>
        <item>
            <title>Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study.</title>
            <link>http://www.medworm.com/index.php?rid=5142967&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21852391%26dopt%3DAbstract</link>
            <description>Conclusions. Low T and higher E2 correlate with increased risk of CVD and CV mortality. TRT in hypogonadism moderates metabolic components associated with CV risk. Whether low T is just an association with CV risk, or an actual cause and effect relationship, awaits further studies.
    PMID: 21852391 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5142967</comments>
            <pubDate>Wed, 17 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5142967</guid>        </item>
        <item>
            <title>High allele frequency of the p.Q258X mutation and identification of a novel mis-splicing mutation in the StAR gene in Korean patients with congenital lipoid adrenal hyperplasia.</title>
            <link>http://www.medworm.com/index.php?rid=5142969&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21846663%26dopt%3DAbstract</link>
            <description>Conclusions: p.Q258X is the most common StAR mutation in Korea. A previously reported c.653C&amp;gt;T variant was found to cause aberrant splicing at the mRNA level, resulting in perturbation of StAR function. The c.745-6_810del mutation also resulted in aberrant splicing.
    PMID: 21846663 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5142969</comments>
            <pubDate>Mon, 15 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5142969</guid>        </item>
        <item>
            <title>RBP4 - a controversial adipokine.</title>
            <link>http://www.medworm.com/index.php?rid=5142970&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21835764%26dopt%3DAbstract</link>
            <description>Authors: Kotnik P, Fischer-Posovszky P, Wabitsch M
    Abstract
    Adipose tissue is an endocrine organ, secreting biologically active factors called adipokines that act both locally and on distant tissues. Adipokines have an important role in the development of obesity related co-morbidities not only in adults but also in children and adolescents. Retinol binding protein 4 (RBP4) is a recently identified adipokine suggested to link obesity with its co-morbidities, especially insulin resistance, type 2 diabetes and certain components of the metabolic syndrome. However, data, especially results from the clinical studies, are conflicting. In this review we summarize up-to-date knowledge on RBP4s role in obesity, development of insulin resistance and T2D. Special attention is devoted to stud...</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5142970</comments>
            <pubDate>Tue, 09 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5142970</guid>        </item>
        <item>
            <title>ALTERED URINARY EXCRETION OF AQUAPORIN-2 IN IgA NEPHROPATHY.</title>
            <link>http://www.medworm.com/index.php?rid=5112649&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21824900%26dopt%3DAbstract</link>
            <description>Conclusion: our findings would support the involvement of AVP-AQP2 axis, interacting with the RAS, in the progression of IgAN, and candidate AQP2 as a possible novel marker of the disease.
    PMID: 21824900 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112649</comments>
            <pubDate>Sun, 07 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112649</guid>        </item>
        <item>
            <title>Modifications of bone material properties in postmenopausal osteoporotic women long-term treated with alendronate.</title>
            <link>http://www.medworm.com/index.php?rid=5112650&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21821631%26dopt%3DAbstract</link>
            <description>Conclusion: Increased degree of mineralization associated with lower crystallinity and microhardness in ALN long-term-treated PMOP women suggests that ALN could alter the quality of bone matrix. The study also suggested that after three years of treatment, the changes in material properties are not dependent of the treatment duration. Further studies are requested to assess the short-term (&amp;lt; 3 years) effects of bisphosphonates on bone intrinsic properties.
    PMID: 21821631 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112650</comments>
            <pubDate>Thu, 04 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112650</guid>        </item>
        <item>
            <title>Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high T3/T4 ratio after thyroidectomy.</title>
            <link>http://www.medworm.com/index.php?rid=5112651&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21813593%26dopt%3DAbstract</link>
            <description>Conclusions: Our results implicate peripheral deiodination in the peculiar hormonal constellation of MCT8-deficient patients. Other MCT8-deficient patients should be closely monitored for potential thyroid abnormalities.
    PMID: 21813593 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112651</comments>
            <pubDate>Tue, 02 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112651</guid>        </item>
        <item>
            <title>Identification of Somatostatin Receptor Type 5 (SSTR5) gene polymorphisms associated with acromegaly.</title>
            <link>http://www.medworm.com/index.php?rid=5112652&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810856%26dopt%3DAbstract</link>
            <description>Conclusions: Our results demonstrate a previously undetected strong association of two SSTR5 SNPs with acromegaly. The data also suggest a possible involvement of SSTR5 variants in decreased suppression of growth hormone (GH) production and increased tumor proliferation.
    PMID: 21810856 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112652</comments>
            <pubDate>Mon, 01 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112652</guid>        </item>
        <item>
            <title>Isolated Growth Hormone Deficiency: mutation screening and copy number analysis of HMGA2 and CDK6 genes.</title>
            <link>http://www.medworm.com/index.php?rid=5112654&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21803798%26dopt%3DAbstract</link>
            <description>Conclusions: This study provides the first report of a deletion in the HMGA2 gene that might be related to IGHD. We suggest that this gene be investigated as a second screening in patients with a classical IGHD phenotype in whom mutations in classical candidate genes have been excluded.
    PMID: 21803798 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112654</comments>
            <pubDate>Thu, 28 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112654</guid>        </item>
        <item>
            <title>Circulating glucagon is associated with inflammatory mediators in metabolically compromised subjects.</title>
            <link>http://www.medworm.com/index.php?rid=5112659&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21798957%26dopt%3DAbstract</link>
            <description>Conclusions: According to current results, acute phase reactants such as IL-6 and CFB are associated with fasting glucagon in metabolically compromised subjects. This suggests that glucagon may be behind the association between inflammatory and metabolic parameters in obesity-associated chronic low-grade inflammation.
    PMID: 21798957 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112659</comments>
            <pubDate>Wed, 27 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112659</guid>        </item>
        <item>
            <title>Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5112658&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21798958%26dopt%3DAbstract</link>
            <description>Conclusions: Patients after long-term remission of CS report more negative illness perceptions compared to patients with other acute or chronic conditions. Further research is needed to assess whether QoL in CS can be improved by addressing these illness perceptions, for example by a self-management intervention program.
    PMID: 21798958 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112658</comments>
            <pubDate>Wed, 27 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112658</guid>        </item>
        <item>
            <title>Serum vaspin levels in hypothyroid patients.</title>
            <link>http://www.medworm.com/index.php?rid=5112657&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21798959%26dopt%3DAbstract</link>
            <description>Conclusion: We herein present a novel data indicating vaspin levels are neither altered in overt and subclinical hypothyroidism nor have a relationship with features of insulin resistance in hypothyroid patients.
    PMID: 21798959 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112657</comments>
            <pubDate>Wed, 27 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112657</guid>        </item>
        <item>
            <title>Skeletal Muscle Mitochondrial Function in Polycystic Ovarian Syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5112656&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21798960%26dopt%3DAbstract</link>
            <description>Conclusions In contrast to previous reports we found no evidence that skeletal muscle mitochondrial respiration is reduced in skeletal muscle of women with PCOS compared to control subjects. Furthermore, mitochondrial content did not differ between our control and PCOS groups. These results question the causal relationship between reduced mitochondrial function and skeletal muscle insulin resistance in PCOS.
    PMID: 21798960 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112656</comments>
            <pubDate>Wed, 27 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112656</guid>        </item>
        <item>
            <title>Plasma adrenomedullin level is related to a single nucleotide polymorphism in the adrenomedullin gene.</title>
            <link>http://www.medworm.com/index.php?rid=5112655&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21798961%26dopt%3DAbstract</link>
            <description>Conclusion: Plasma adrenomedullin correlates with plasma IL-6 level, consistent with its role in inflammation. It is related to an SNP common in Chinese, independent of other covariates. Adrenomedullin genotype should be included in future studies of cardiovascular risk prediction.
    PMID: 21798961 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112655</comments>
            <pubDate>Wed, 27 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112655</guid>        </item>
        <item>
            <title>&quot;Idiopathic&quot; partial androgen insensitivity syndrome in 28 newborn and infant males: impact of prenatal exposure to environmental endocrine-disruptor chemicals?</title>
            <link>http://www.medworm.com/index.php?rid=5112660&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21788424%26dopt%3DAbstract</link>
            <description>Conclusions: Our results indicate that the &quot;idiopathic&quot; PAIS-like phenotype may in some cases be related to EDC contamination during fetal life.
    PMID: 21788424 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112660</comments>
            <pubDate>Sun, 24 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112660</guid>        </item>
        <item>
            <title>Elevated Plasma Levels of SPARC in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.</title>
            <link>http://www.medworm.com/index.php?rid=5112661&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21778250%26dopt%3DAbstract</link>
            <description>Conclusion The present work indicates a potential link between SPARC and the pathogenesis of T2DM.
    PMID: 21778250 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112661</comments>
            <pubDate>Wed, 20 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112661</guid>        </item>
        <item>
            <title>Fetal and infant growth and the risk of obesity during early childhood. The Generation R Study.</title>
            <link>http://www.medworm.com/index.php?rid=5112663&amp;cid=s_37945_15_f&amp;fid=37945&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21775498%26dopt%3DAbstract</link>
            <description>Conclusion: Fetal growth characteristics strongly influence infant growth rates. A higher PWV, which generally occurs in the first month after birth, was associated with an increased risk of overweight and obesity at 4 years of age. Longer follow-up studies are necessary to determine how fetal and infant growth patterns affect the risk of disease in later life.
    PMID: 21775498 [PubMed - as supplied by publisher] (Source: European Journal of Endocrinology)</description>
            <author>European Journal of Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112663</comments>
            <pubDate>Tue, 19 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5112663</guid>        </item>
    </channel>
</rss>

